Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer
- Shengjing Hospital of China Medical Universit, China
- Shengjing Hospital of China Medical University, China
- Jiangsu Hengrui Pharmaceuticals Co Ltd, China
Additional files
-
All additional files
Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.
- https://cdn.elifesciences.org/articles/85246/elife-85246-supp-v1.zip
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer
eLife 12:e85246.
https://doi.org/10.7554/eLife.85246
